Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00522925
Status:
COMPLETED
Last Update Posted:
2011-09-16
First Post:
2007-08-29
Brief Title:
A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension
Sponsor:
Ligand Pharmaceuticals
Organization:
Ligand Pharmaceuticals
Study Overview
Official Title:
Prospective Randomized Double-Blind Placebo-Controlled Parallel-Group Study to Evaluate the Safety and Efficacy of a Novel Dual Angiotensin and Endothelin Receptor Antagonist PS433540 in Subjects With Stage I and II Hypertension
Status:
COMPLETED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to see if PS433540 lowers blood pressure better than placebo and to see how safe PS433540 is compared to placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None